ESC Guidelines 2021 on valvular heart disease

ESC Cardio Talk
06/10/2021 10 min
ESC Guidelines 2021 on valvular heart disease

Listen "ESC Guidelines 2021 on valvular heart disease"

Descargar episodio Ver en sitio original

Episode Synopsis

With Friedhelm Beyersdorf, University Heart Center Freiburg, Bad Krozingen - Germany & Alec Vahanian, University Paris-Descartes, Paris - France Link to paper

More episodes of the podcast ESC Cardio Talk

Journal editorial - The emerging story of Myval transcatheter heart valve: lessons from the LANDMARK trial 24/11/2025
Journal editorial: The dilemma of a correct patient selection for implantable cardioverter defibrillator in non-ischaemic cardiomyopathy 17/11/2025
Journal editorial: Is routine imaging follow-up after LAA closure necessary? 10/11/2025
Journal Editorial: Perioperative discontinuation of renin–angiotensin system inhibitors in non-cardiac surgery: is it time to change what we tell our patients? 20/10/2025
Journal editorial: Arrhythmic risk and advanced heart failure in dilated cardiomyopathy: a deadly tango 20/10/2025
Journal editorial: ApoB and Lp(a): core measures to assess cardiovascular risk 06/10/2025
Journal editorial: With a little HELP from heparin at first medical contact before primary percutaneous coronary intervention 29/09/2025
Journal editorial - Residual cardiovascular risk beyond low-density lipoprotein cholesterol: inflammation, remnant cholesterol, and lipoprotein(a) 15/09/2025
Journal editorial - Has artificial intelligence proven stress perfusion cardiac computed tomography obsolete or more relevant than ever? 04/08/2025
Journal editorial - When coronary plaque is found in everyone: is anyone really at risk? 12/07/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA